The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21509
Abstract: Acquired hemophilia A (AHA) is a rare autoimmune disorder that leads to factor VIII (FVIII) deficiency via autoantibody formation. Standard treatment options include FVIII bypassing factors and immunosuppression. However, the role of therapeutic plasma exchange… read more here.
Keywords: inhibitor; acquired hemophilia; treatment; fviii inhibitor ... See more keywords